NO20001893L - FremgangsmÕte for behandling av dyskinesi relatert til sykdom eller som er indusert av medikamenter - Google Patents

FremgangsmÕte for behandling av dyskinesi relatert til sykdom eller som er indusert av medikamenter

Info

Publication number
NO20001893L
NO20001893L NO20001893A NO20001893A NO20001893L NO 20001893 L NO20001893 L NO 20001893L NO 20001893 A NO20001893 A NO 20001893A NO 20001893 A NO20001893 A NO 20001893A NO 20001893 L NO20001893 L NO 20001893L
Authority
NO
Norway
Prior art keywords
medication
induced
disease
procedure
treatment
Prior art date
Application number
NO20001893A
Other languages
English (en)
Other versions
NO20001893D0 (no
Inventor
Leonard Theodore Meltzer
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of NO20001893L publication Critical patent/NO20001893L/no
Publication of NO20001893D0 publication Critical patent/NO20001893D0/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/453—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with oxygen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/451—Non condensed piperidines, e.g. piperocaine having a carbocyclic group directly attached to the heterocyclic ring, e.g. glutethimide, meperidine, loperamide, phencyclidine, piminodine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Neurosurgery (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20001893A 1997-10-24 2000-04-12 Fremgangsmõte for behandling av dyskinesi relatert til sykdom eller som er indusert av medikamenter NO20001893D0 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6315697P 1997-10-24 1997-10-24
PCT/US1998/019357 WO1999021539A1 (en) 1997-10-24 1998-09-16 Method for treating disease-related or drug-induced dyskinesias

Publications (2)

Publication Number Publication Date
NO20001893L true NO20001893L (no) 2000-04-12
NO20001893D0 NO20001893D0 (no) 2000-04-12

Family

ID=22047302

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001893A NO20001893D0 (no) 1997-10-24 2000-04-12 Fremgangsmõte for behandling av dyskinesi relatert til sykdom eller som er indusert av medikamenter

Country Status (15)

Country Link
US (1) US6284776B1 (no)
EP (1) EP1024799A1 (no)
JP (1) JP2001520988A (no)
KR (1) KR20010024548A (no)
AU (1) AU760800B2 (no)
BR (1) BR9814867A (no)
CA (1) CA2299400C (no)
HU (1) HUP0004900A3 (no)
IL (1) IL134363A0 (no)
IS (1) IS5384A (no)
NO (1) NO20001893D0 (no)
NZ (1) NZ502785A (no)
PL (1) PL340080A1 (no)
WO (1) WO1999021539A1 (no)
ZA (1) ZA989693B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1436258A4 (en) * 2001-03-08 2005-03-23 Univ Emory ANTAGONISTS OF THE NMDA RECEPTOR DEPENDENT OF PH
CA2381630A1 (en) * 2001-04-23 2002-10-23 Leonard Theodore Meltzer Method for preventing dyskinesias
CZ2004233A3 (cs) 2001-07-24 2004-12-15 Richter Gedeon Vegyészeti Gyár Rt. Nové amidové sloučeniny karboxylové kyseliny
US7160913B2 (en) * 2002-09-13 2007-01-09 Thomas Jefferson University Methods and kit for treating Parkinson's disease
EP1673366A1 (en) * 2003-10-08 2006-06-28 Pfizer, Inc. 1-"2-(4-hydroxyphenyl)-2-hydroxyethyl]-piperidin-4-ol compounds as nmda receptor antagonists
EP2170334B1 (en) * 2007-06-29 2021-03-17 Emory University Nmda receptor antagonists for neuroprotection
US8951968B2 (en) 2009-10-05 2015-02-10 Northwestern University Methods of treating depression and other related diseases
KR20140097132A (ko) 2011-11-22 2014-08-06 더 리젠츠 오브 더 유니버시티 오브 캘리포니아 허혈성 손상을 치료하기 위한 시스테아민 및/또는 시스타민
US10752588B2 (en) 2014-12-19 2020-08-25 The Broad Institute, Inc. Dopamine D2 receptor ligands
WO2016100940A1 (en) 2014-12-19 2016-06-23 The Broad Institute, Inc. Dopamine d2 receptor ligands

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR5733M (no) 1966-09-27 1968-01-22
US5272160A (en) 1989-05-17 1993-12-21 Pfizer Inc 2-piperidino-1-alkanol derivatives as antiischemic agents
CA2069318A1 (en) * 1989-10-27 1991-04-28 Engelbert Ciganek (n-phthalimidoalkyl) piperidines
US5356906A (en) * 1989-10-27 1994-10-18 The Du Pont Merck Pharmaceutical Company (N-phthalimidoalkyl) piperidines useful as treatments for psychosis
US5116846A (en) * 1990-03-28 1992-05-26 Du Pont Merck Pharmaceutical Company N-aralkyl piperidine derivatives as psychotropic drugs
JPH06509069A (ja) * 1991-06-27 1994-10-13 バージニア・コモンウェルス・ユニバーシティ シグマレセプターリガンドおよびその用途
US5364867A (en) * 1992-11-30 1994-11-15 Sterling Winthrop Inc. 4-phenylpiperdine agents for treating cns disorders
TW281670B (no) 1993-09-02 1996-07-21 Hoffmann La Roche
FR2717080B1 (fr) 1994-03-09 1996-12-13 Synthelabo Utilisation de l'éliprodil et de ses énantiomères pour la préparation de médicaments utiles dans le traitement des neuropathies périphériques et des maladies neurodégénératives centrales.
FR2717810B1 (fr) * 1994-03-22 1996-04-26 Adir Nouvelles aminoalkyl benzoxazolinones et benzothiazolinones, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
WO1996037226A2 (en) * 1995-05-26 1996-11-28 Pfizer Inc. Combinations for the treatment of parkinsonism containing selective nmda antagonists
ZA9610741B (en) 1995-12-22 1997-06-24 Warner Lambert Co 4-Substituted piperidine analogs and their use as subtype selective nmda receptor antagonists
ZA9610745B (en) * 1995-12-22 1997-06-24 Warner Lambert Co 4-Subsituted piperidine analogs and their use as subtype selective nmda receptor antagonists

Also Published As

Publication number Publication date
EP1024799A1 (en) 2000-08-09
IS5384A (is) 2000-02-25
WO1999021539A1 (en) 1999-05-06
AU9318198A (en) 1999-05-17
HUP0004900A2 (hu) 2001-06-28
US6284776B1 (en) 2001-09-04
CA2299400C (en) 2004-04-27
ZA989693B (en) 1999-04-29
BR9814867A (pt) 2000-10-03
PL340080A1 (en) 2001-01-15
KR20010024548A (ko) 2001-03-26
JP2001520988A (ja) 2001-11-06
CA2299400A1 (en) 1999-05-06
HUP0004900A3 (en) 2002-03-28
AU760800B2 (en) 2003-05-22
NO20001893D0 (no) 2000-04-12
NZ502785A (en) 2003-03-28
IL134363A0 (en) 2001-04-30

Similar Documents

Publication Publication Date Title
DK0730864T3 (da) Lægemiddel til behandling af inflammatoriske hjertesygdomme
EE04156B1 (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
DK0769947T3 (da) Indolinonforbindelser til behandling af sygdom
EE200300214A (et) Sulfoonamiidid endoteliini vahendatud haiguste ravimiseks
DK0941103T3 (da) Farmaceutisk præparat til behandling af diabetes
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
NO20010882D0 (no) Terapier for behandling av lungesykdommer
NO20001195L (no) Bruddheling ved anvendelse av PTHrP-analoger
NO20022087D0 (no) Fremgangsmåte for behandling av diabetes
FI953899A0 (fi) Substituoituja atsolonijohdannaisia Helicobacterin aiheuttamien sairauksien hoitamiseksi
DK0979079T3 (da) Anvendelse af tetrahydropyridinderivater til fremstilling af lægemidler til behandling af sygdomme, der medförer en demyelinisering
NO20001893L (no) FremgangsmÕte for behandling av dyskinesi relatert til sykdom eller som er indusert av medikamenter
NO20033622L (no) Fremgangsmate for behandling av demyeliniserende sykdommer eller tilstander
ITTO960495A0 (it) Procedimento per accrescere il flusso per elettrotrasporto di polipep-tidi.
NO991459L (no) Anvendelse av 1-hydroksy-2-pyridoner til behandling av hudinfeksjoner
AU4376396A (en) Use of andrographolide compounds to treat or prevent pathogenicity of diseases
NO985029D0 (no) Forbedring av, eller med hensyn til, synkronisering
IT1272922B (it) Procedimento per la preparazione di composti metallocenici
MX26167A (es) Derivados de acido piridil-benzoico para el tratamiento de enfermedades relacionadas con lecotrino.
NO20001523D0 (no) Fremgangsmåte for fremstilling av flytende hydrokarboner
EE200000055A (et) Protsess tsüklopropüülatsetüleeni valmistamiseks
NO20020784D0 (no) Medikament for behandling av brudd
ID21369A (id) Komposisi farmasi untuk penyembuhan penyakit yang disebabkan oleh virus
NO985030D0 (no) Forbedring av, eller med hensyn til, synkronisering
NO20011103D0 (no) Lokal avlevering av legemidler til hjertet

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application